The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy: Two-Year Follow-Up Results
Open accessAbstract
Background —Previous studies have shown disappointing results for immunosuppressive treatment in patients with dilated cardiomyopathy. Therefore, we studied the effectiveness of such therapy in patients with HLA upregulation on biopsy. Methods and Results —Of 202 patients with dilated cardiomyopathy, 84 patients with increased HLA expression were randomized to receive either immunosuppression or placebo for 3 months; they were then followed for 2 years. After 2 years, there were no significant differences in the primary end point (a composite of death, heart transplantation, and hospital readmission) between the 2 study groups (22.8% for the immunosuppression group and 20.5% for the placebo). The secondary efficacy end point included changes in ejection fraction, end-diastolic diameter, end-diastolic volume, end-systolic volume and NYHA class; left ventricular ejection fraction increased significantly in the immunosuppression group compared with the placebo group (95% CI, 4.20 to 13.12; P <0.001) after 3 months of follow-up. The early favorable effects of immunosuppressive therapy on left ventricular volume, left ventricular diastolic dimension, and New York Heart Association class were also present. This improvement was maintained in the immunosuppression group at 2 years (ejection fraction: 95% CI, 6.94 to 19.04; P <0.001). In addition, on the basis of the protocol-specified definition of improvement, 71.8% patients in the immunosuppression group versus 20.9% patients in the placebo group met the criteria of improvement after 3 months ( P <0.001). At the end of the follow-up period, 71.4% patients from the immunosuppression group versus 30.8% patients from the placebo group were improved ( P =0.001). Conclusions —These data demonstrate a long-term benefit of immunosuppressive therapy in patients with dilated cardiomyopathy and HLA upregulation on biopsy specimens. Thus, restoration of immunosuppressive therapy for such patients should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · Circulation · doi:10.1161/01.cir.93.5.841 · Cited by 3,458 · cited 1×
“(1) An intention-to-treat analysis with the 2-tailed Fisher’s exact test included all randomized patients (except patients who withdrew) for all follow-up end points.”
MethodA Clinical Trial of Immunosuppressive Therapy for Myocarditis
Mason, J. W., O'Connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., & Moon, T. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330501 · Cited by 1,274
Idiopathic Dilated Cardiomyopathy
Dec, G. W., & Fuster, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412083312307 · Cited by 963
Feldman, A. M., & McNamara, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431908 · Cited by 958
Myocarditis: The Dallas criteria
Thomas Aretz, H. (1987) · Human Pathology · doi:10.1016/s0046-8177(87)80363-5 · Cited by 809
Kawai, C. (1999) · Circulation · doi:10.1161/01.cir.99.8.1091 · Cited by 552
Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis
Chow, L. H., Radio, S. J., Sears, T. D., & Mcmanus, B. M. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90465-8 · Cited by 355
A Prospective, Randomized, Controlled Trial of Prednisone for Dilated Cardiomyopathy
Parrillo, J. E., Cunnion, R. E., Epstein, S. E., Parker, M. M., Suffredini, A. F., Brenner, M., Schaer, G. L., Palmeri, S. T., Cannon, R. O., Alling, D., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910193211601 · Cited by 353
Magnusson, Y., Wallukat, G., Waagstein, F., Hjalmarson, A., & Hoebeke, J. (1994) · Circulation · doi:10.1161/01.cir.89.6.2760 · Cited by 347
Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy
Caforio, A. L. P., Bonifacio, E., Stewart, J. T., Neglia, D., Parodi, O., Bottazzo, G. F., & Mckenna, W. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)92821-i · Cited by 205
The Clinical Course of Idiopathic Dilated Cardiomyopathy: A Population-based Study
Sugrue, D. D., Rodeheffer, R. J., Codd, M. B., Ballard, D. J., Fuster, V., & Gersh, B. J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-117 · Cited by 200
Noutsias, M., Seeberg, B., Schultheiss, H.-P., & Kühl, U. (1999) · Circulation · doi:10.1161/01.cir.99.16.2124 · Cited by 193
Grogan, M., Redfield, M. M., Bailey, K. R., Reeder, G. S., Gersh, B. J., Edwards, W. D., & Rodeheffer, R. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00148-s · Cited by 185
Sole, M. J., & Liu, P. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90470-l · Cited by 159
Mechanisms of immune-mediated myocyte injury.
Barry, W. H. (1994) · Circulation · doi:10.1161/01.cir.89.5.2421 · Cited by 140
Herskowitz, A., Ahmed‐Ansari, A., Neumann, D., Beschorner, W. E., Rose, N. R., Soule, L., Burek, C. L., Sell, K. W., & Baughman, K. L. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90637-5 · Cited by 131
Latham, R. D., Mulrow, J. P., Virmani, R., Robinowitz, M., & Moody, J. M. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90626-1 · Cited by 85
Ansari, A. A., Wang, Y., Danner, D. J., Gravanis, M. B., Mayne, A. E., Neckelmann, N., Sell, K. W., & Herskowitz, A. (1991) · PubMed Central · Cited by 75
Endomyocardial Biopsy in Patients with Unexplained Congestive Heart Failure
Chow, L. C., Dittrich, H. C., & Shabetai, R. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-7-535 · Cited by 74
Tanio, J. W., Basu, C., Albelda, S. Μ., & Eisen, H. J. (1994) · Circulation · doi:10.1161/01.cir.89.4.1760 · Cited by 73
Wojnicz, R., Nowalany-Kozielska, E., Wodniecki, J., Szczurek-Katański, K., Nozyński, J., Zembala, M., & Rozek, M. M. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1085 · Cited by 70
Self-citationHammond, E. H., Menlove, R. L., & Anderson, J. L. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90180-3 · Cited by 69
The role of myocarditis in end-stage dilated cardiomyopathy.
O'Connell, J. B. (1987) · Europe PMC (PubMed Central) · Cited by 63
Autoimmunity in Myocarditis: Models and Mechanisms
Rose, N. R., Herskowitz, A., & Neumann, D. A. (1993) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1993.1102 · Cited by 63
Badorff, C., Noutsias, M., Kühl, U., & Schultheiß, H. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00475-5 · Cited by 59
Immunosuppressive treatment in autoreactive myocarditis--results from a controlled trial.
Maisch, B., Schönian, U., Hengstenberg, C., Herzum, M., Hufnagel, G., Bethge, C., Bittinger, A., & Neumann, K. (1994) · PubMed · Cited by 44
Cappato, R., Codecà, L., Guardigli, G., Toselli, T., Antonioli, G., & Alboni, P. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90822-i · Cited by 39
Cited by
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
Cooper, L. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0800028 · Cited by 1,318
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hübner, N., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00435-x · Cited by 1,217
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.186093 · Cited by 1,030
Kindermann, I., Barth, C., Mahfoud, F., Ukena, C., Lenski, M., Yilmaz, A., Klingel, K., Kandolf, R., Sechtem, U., Cooper, L. T., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.09.074 · Cited by 919
Metadata
- Authors
- Wojnicz, R., Nowalany-Kozielska, E., Wojciechowska, C., Glanowska, G., Wilczewski, P., Niklewski, T., Zembala, M., Poloński, L., Rozek, M. M., & Wodniecki, J.
- Venue
- Circulation
- Published
- 2001-07-03
- Volume
- 104
- Issue
- 1
- Pages
- 39-45
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2111652408
- Cited by
- 459
- References
- 27
- FWCI
- 11.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.